A detailed history of Claret Asset Management Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Claret Asset Management Corp holds 7,291 shares of NVO stock, worth $816,154. This represents 0.19% of its overall portfolio holdings.

Number of Shares
7,291
Previous 7,966 8.47%
Holding current value
$816,154
Previous $1.02 Million 1.76%
% of portfolio
0.19%
Previous 0.17%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $82,829 - $99,164
-675 Reduced 8.47%
7,291 $1.04 Million
Q1 2024

Apr 29, 2024

BUY
$102.11 - $135.92 $66,371 - $88,347
650 Added 8.88%
7,966 $1.02 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $335,659 - $736,502
3,691 Added 101.82%
7,316 $665,000
Q4 2021

Feb 07, 2022

SELL
$95.88 - $117.08 $3,451 - $4,214
-36 Reduced 0.98%
3,625 $406,000
Q4 2020

Feb 02, 2021

SELL
$63.89 - $73.8 $19,678 - $22,730
-308 Reduced 7.76%
3,661 $256,000
Q2 2020

Aug 06, 2020

SELL
$58.54 - $67.94 $233,574 - $271,080
-3,990 Reduced 50.13%
3,969 $260,000
Q1 2020

Apr 06, 2020

SELL
$49.46 - $64.78 $84,329 - $110,449
-1,705 Reduced 17.64%
7,959 $479,000
Q4 2019

Jan 07, 2020

SELL
$49.86 - $58.26 $3,440 - $4,019
-69 Reduced 0.71%
9,664 $559,000
Q3 2019

Oct 11, 2019

SELL
$47.54 - $53.43 $2,234 - $2,511
-47 Reduced 0.48%
9,733 $503,000
Q1 2019

Apr 29, 2019

BUY
$46.36 - $52.63 $2,178 - $2,473
47 Added 0.48%
9,780 $512,000
Q3 2018

Oct 30, 2018

BUY
$46.76 - $51.24 $42,271 - $46,320
904 Added 10.24%
9,733 $459,000
Q2 2018

Aug 13, 2018

BUY
$44.29 - $50.42 $199,305 - $226,890
4,500 Added 103.95%
8,829 $407,000
Q4 2017

Mar 27, 2018

BUY
$47.53 - $53.73 $205,757 - $232,597
4,329
4,329 $232,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Claret Asset Management Corp Portfolio

Follow Claret Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.